Skip to content
10-K

Annual Report

CHINA PHARMA HOLDINGS, INC. CPHI

0001213900-25-026280

← back to feed
Filed
Mar 31, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 24, 2025 32.62M sh
Capex FY 2024 · Dec 31, 2023 $11.52K
Operating Cash Flow FY 2024 · Dec 31, 2023 −$699.69K
Short Term Debt FY 2024 · Dec 31, 2023 $1.13M
Current Liabilities FY 2024 · Dec 31, 2023 $6.82M
Total Liabilities FY 2024 · Dec 31, 2023 $9.01M
Current Assets FY 2024 · Dec 31, 2023 $6M
Total Assets FY 2024 · Dec 31, 2023 $16.47M
Eps Diluted FY 2024 · Dec 31, 2023 −$0.91
Eps Basic FY 2024 · Dec 31, 2023 −$0.91
Sga Expense FY 2024 · Dec 31, 2023 $1.47M
Rd Expense FY 2024 · Dec 31, 2023 $240.08K
Net Income FY 2024 · Dec 31, 2023 −$3.08M
Operating Income FY 2024 · Dec 31, 2023 −$2.75M
Gross Profit FY 2024 · Dec 31, 2023 −$281.09K
Cost Of Revenue FY 2024 · Dec 31, 2023 $7.29M
Revenue FY 2024 · Dec 31, 2023 $7.01M
Stockholders Equity FY 2024 · Dec 31, 2022 $4.29M